BioAlberta works with policymakers at all levels for a coordinated approach to setting public policy initiatives and ensuring the life sciences industry’s critical issues are well represented.
However, we also work with partner life science organizations across the country to support federal regulatory issues. Our Advocacy and Policy Committee is divided into subcommittees to answer the unique needs of each of the life science sectors.
Priority activities include:
This commentary by W. Neil Palmer argues that the PMPRB has demonstrated little to no interest in patient health or health outcomes. It is time that changed.
November 1, 2022
Subject: The struggle to access investment capital for Alberta companies
MARCH 4, 2020